Support is requested for continuation of the Training Program in Cancer Biology at the University of California, Irvine. This program, administered by the UCI Cancer Research Institute, is entering its 32nd year and is a broad-based training program in basic cancer-related research, encompassing faculty from the School of Biological Sciences, basic and clinical departments in the College of Medicine, and the department of Chemistry in the School of Physical Sciences. There are thirty-eight training faculty;support for six postdoctorals and four predoctorals is requested. Faculty research concentrations are in cell transformation and carcinogenesis;growth factors and cell signaling;cancer genetics;and experimental therapeutics. Predoctoral students are recruited through the joint graduate program in Molecular Biology, Genetics and Biochemsitry and the department of Chemistry. Predoctorals are typically supported for three years, and postdoctorals for two years. Trainees typically take research positions in academia, research institutions, or industry following their training. Features of this training program include (in addition to laboratory research) training grant courses ("Clinical Cancer for Basic Scientists", "Cancer Biology parts A and B", "Cancer Biology Journal Club", "Responsible Conduct of Research"), attendance at the UCI Cancer Center annual scientific retreat, an extensive series of national meetings, and regular multidisciplinary retreats. The UCI Chao Family Comprehensive Cancer Center (of which the Cancer Research Institute is the basic science arm) is an NCI-designated comprehensive cancer center. This enhances the possibilities for translational research.

National Institute of Health (NIH)
National Cancer Institute (NCI)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Subcommittee G - Education (NCI)
Program Officer
Lim, Susan E
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of California Irvine
Internal Medicine/Medicine
Organized Research Units
United States
Zip Code
Popson, Stephanie A; Ziegler, Mary E; Chen, Xiaofang et al. (2014) Interferon-induced transmembrane protein 1 regulates endothelial lumen formation during angiogenesis. Arterioscler Thromb Vasc Biol 34:1011-9
Zeng, Weihua; Chen, Yen-Yun; Newkirk, Daniel A et al. (2014) Genetic and epigenetic characteristics of FSHD-associated 4q and 10q D4Z4 that are distinct from non-4q/10q D4Z4 homologs. Hum Mutat 35:998-1010
Dellinger, Ryan W; Garcia, Angela M Gomez; Meyskens Jr, Frank L (2014) Differences in the glucuronidation of resveratrol and pterostilbene: altered enzyme specificity and potential gender differences. Drug Metab Pharmacokinet 29:112-9
Nishino, Noriko; Hollingsworth, Scott A; Stern, Abraham C et al. (2014) Interactions of gaseous HNO3 and water with individual and mixed alkyl self-assembled monolayers at room temperature. Phys Chem Chem Phys 16:2358-67
Mallya, Sharmila; Fitch, Briana A; Lee, J Scott et al. (2014) Resistance to mTOR kinase inhibitors in lymphoma cells lacking 4EBP1. PLoS One 9:e88865
Madrona, Yarrow; Hollingsworth, Scott A; Tripathi, Sarvind et al. (2014) Crystal structure of cindoxin, the P450cin redox partner. Biochemistry 53:1435-46
Guenther, G G; Liu, G; Ramirez, M U et al. (2014) Loss of TSC2 confers resistance to ceramide and nutrient deprivation. Oncogene 33:1776-87
Madrona, Yarrow; Hollingsworth, Scott A; Khan, Bushra et al. (2013) P450cin active site water: implications for substrate binding and solvent accessibility. Biochemistry 52:5039-50
Wassman, Christopher D; Baronio, Roberta; Demir, Ozlem et al. (2013) Computational identification of a transiently open L1/S3 pocket for reactivation of mutant p53. Nat Commun 4:1407
Janes, M R; Vu, C; Mallya, S et al. (2013) Efficacy of the investigational mTOR kinase inhibitor MLN0128/INK128 in models of B-cell acute lymphoblastic leukemia. Leukemia 27:586-94

Showing the most recent 10 out of 136 publications